Monographie - Pentamidine isetionate

Laatste update :
08/05/2024

Pentamidine isetionate

Molecuulstructuur

Merknamen in verschillende landen

Handelsnamen zijn slechts een indicatie; de samenstelling van hulpstoffen kan per land variëren afhankelijk van de fabrikant

DBL Pentamidine isetionate	Maleisië
Manicare	Argentinië
Nebupent	USA
Pentacarinat	België, Colombia, Denemarken, Duitsland, Finland, Frankrijk, Griekenland, Groot Britannië, Italië, Luxemburg, Nederland, Nieuw Zeeland, Oostenrijk, Spanje, Zweden, Zwitserland
Pentam	USA
Pentamidina	Argentinië, Spanje
Pentamidine isethionate	Australië, Canada, Maleisië, USA
Pentamina	Portugal

Literatuur : Pentamidine isetionate

	Type	Publicatie
36	Artikel	Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73	Artikel	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
198	Artikel	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
275	Artikel	Lewis JD, El-Gendy A. Cephalosporin-pentamidine isethionate incompatibilities. Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337	Artikel	Bashaw ED, Amantea MA, Minor JR, Galleli JF. Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Am J Hosp Pharm 1988 ; 45: 2532-2533.
424	Artikel	De NC, Alam AS, Kapoor JN. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections. Am J Hosp Pharm 1986 ; 43: 1486-1488.
496	Artikel	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
604	Fabrikant	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
1135	Artikel	Baltz JK, Kennedy P, Minor JR, Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235	Artikel	Leigh PH, Buddle GC. Pentamidine infusion stability. Br J Pharm Pract 1988 ; 10: 22-23.
1625	Artikel	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1925	Artikel	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
3543	Fabrikant	Ceftazidime – Summary of Product Characteristics Wockhardt 2013
3559	Fabrikant	Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit Sanofi Aventis France 2013
3560	Fabrikant	Linezolid (Zyvox®) - Summary of Product Characteristics Pharmacia 2013
3662	Fabrikant	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014

Mentions Légales